Navigation Links
Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors
Date:6/2/2011

act additional experienced talent to Pacira's board of directors. We believe that Laura and Paul will together bring important commercial leadership to the board as we approach our upcoming PDUFA (Prescription Drug User Fee Act) date and the potential launch of EXPAREL™ later this year. We look forward to incorporating Laura's and Paul's insights into the execution of the Company's strategy for our planned product launch and rapid growth in future periods."

About Pacira

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL, the company's most advanced investigational product candidate, had been accepted for filing by the U.S. Food and Drug Administration (FDA). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 28, 2011 for the review of the EXPAREL NDA. EXPAREL is a bupivacaine-based product and has completed extensive Phase 3 clinical development for postoperative analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at www.pacira.com.

Forward Looking Statements

Any statements in this press release about our future expectations, plans and prospects, including statements about EXPAREL's potential, and other statements containing the words "believes," "anticipates," "plans," "expects," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigat
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference
2. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
3. Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting
4. Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
5. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
6. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
7. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
8. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
10. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
11. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)...  Today, in final recognition of the Centers for ... 1-800 Contacts is sharing how to keep lens cases ... who do not properly care for their lens cases ... Most contact lens wearers understand the importance ... case is sometimes overlooked.  When proper steps to clean ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Latanoprost Market, 2010-2019" ... by Pharmacia & Upjohn in 1995, latanoprost is ... intraocular pressure. As the first pressure- lowering prostaglandin ... of Xalatan) entered China ...
(Date:8/28/2015)... Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... MYL ) shareholder vote regarding its planned unsolicited offer ... offer to Perrigo shareholders have always been, and will ... of the value available to Perrigo shareholders, and do ... allowed its shareholders to consider," said Joseph C. ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Latanoprost Market Investigation Report 2015-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... Therapeutics, Inc. (NASDAQ: HALO ) today reported ... (Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ) "We ... the European regulatory filing of the subcutaneous Herceptin program ... President and Chief Executive Officer, Halozyme. "Despite the HyQ ...
... be the largest payment ever enforced involving off-label misuse ... Eisenhofer , working with the U.S. Justice Department and ... settlement with Abbott Laboratories over its illegal marketing of ... The settlement was reached between Abbott (NYSE: ...
Cached Medicine Technology:Halozyme Reports First Quarter 2012 Financial Results 2Halozyme Reports First Quarter 2012 Financial Results 3Halozyme Reports First Quarter 2012 Financial Results 4Halozyme Reports First Quarter 2012 Financial Results 5Halozyme Reports First Quarter 2012 Financial Results 6Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote 2Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote 3Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote 4
(Date:8/28/2015)... ... , ... On May 30th, 2015, Best Drug Rehabilitation, a results-based substance abuse ... Mission” benefit concert in Mendon, IL. Held in the Show Barn at the Adams ... education programs in the underfunded local school districts of Mendon at neighboring Quincy, IL. ...
(Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was ... the latest and coolest applications on the market for iOS, Android, and Windows. Joe ... with viewers how this software allows businesses to track product movement from beginning to ...
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the ... Places to Work in Healthcare by Modern Healthcare and will be honored at ... in its eighth year, the Best Places to Work in Healthcare program recognizes outstanding ...
(Date:8/28/2015)... ... ... Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with back pain and associated ... pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan received his Bachelor of ... earn his title of Doctor of Chiropractic from the Palmer College of Chiropractic and ...
(Date:8/28/2015)... ... 2015 , ... Northridge dentists Dr. Elyson and Dr. Assili are ... can currently receive a one hour treatment of this teeth whitening option. Zoom ... number of unique features that can turn teeth up to nine shades whiter. Effective ...
Breaking Medicine News(10 mins):Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2
... , MONDAY, April 9 (HealthDay News) -- People who stay ... because they feel they don,t have a choice are at ... "When employees stay with their organization because they feel ... to experience emotional exhaustion. This feeling, in turn, may lead ...
... Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will ... on their individual genomes and the genomes of their ... sequences: one from the patients, healthy cells before treatment, ... one after. Patients will be paired with mouse "avatars" ...
... News) -- Not only do regular dental exams help keep ... cancer, the Academy of General Dentistry says. As part ... that people get a dental exam from a general dentist ... dentist, ask about an oral cancer screening," academy spokesperson Dr. ...
... more pronounced in individuals with an unacknowledged attraction to ... parents who forbade such desires, a series of psychology ... document the role that both parenting and sexual orientation ... of homosexuals, including self-reported homophobic attitudes, discriminatory bias, implicit ...
... receiving in-patient rehabilitation are more likely to land back ... functioning poorly, show signs of depression and lack social ... Medical Branch (UTMB) at Galveston. Hospital readmission for older ... $18 billion annually. , Among the first of ...
... News) -- Surgery for esophageal cancer can result ... new study finds. Common complaints among patients ... surgery include breathlessness, fatigue, insomnia and eating problems, ... Sweden. Patients who experienced a serious complication after ...
Cached Medicine News:Health News:Mayo Clinic launches whole genome breast cancer study 2Health News:Mayo Clinic launches whole genome breast cancer study 3Health News:Dentists Play Key Role in Detecting Oral Cancer 2Health News:Is some homophobia self-phobia? 2Health News:Is some homophobia self-phobia? 3Health News:Is some homophobia self-phobia? 4Health News:Predictors identified for rehospitalization among post-acute stroke patients 2Health News:Predictors identified for rehospitalization among post-acute stroke patients 3Health News:Esophageal Cancer Surgery Can Leave Lingering Health Problems, Study Says 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: